Concepedia

Author

Annalisa Ronca

University of ParmaORCID

Also Known As

A. Ronca, Annalisa Ronca

16

Publications

161

Citations

7

H-Index

16

Concepts

All Affiliations

University of ParmaUniversity of GenoaOspedale Policlinico San MartinoSapienza University of RomeUniversity of Milan
AR

About

Annalisa Ronca is an author at University of Parma specializing in medicine, cancer research, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

38

2

Public Health

1

1

20

3

Epidemiology

1

1

20

4

Immunology

1

1

18

5

Cancer Therapeutics

1

1

18

Annalisa Ronca

×

7

Publications

142

Citations

7

H-Index

YearCitations

HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)

Alessia Di Costanzo, Annalisa Ronca, Laura D’Erasmo,

Biomedicines

2020

33

Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients

Elena Formisano, Andrea Pasta, Anna Laura Cremonini,

Journal of Medicinal Food

2019

23

Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a)

Claudia Stefanutti, Livia Pisciotta, Elda Favari,

Journal of clinical lipidology

2020

20

Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation

Sabrina Pagano, Alessandra Magenta, M D'agostino,

Journal of Clinical Medicine

2019

19

Plasma HDL pattern, cholesterol efflux and cholesterol loading capacity of serum in carriers of a novel missense variant (Gly176Trp) of endothelial lipase

Livia Pisciotta, Alice Ossoli, Annalisa Ronca,

Journal of clinical lipidology

2022

19

The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors

Fabiana Perrone, Elda Favari, Giuseppe Maglietta,

Cancer Immunology Immunotherapy

2023

18

Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments?

Qidi Ying, Annalisa Ronca, Dick C. Chan,

European Journal of Clinical Investigation

2022

10

Page 1